Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Wockhardt Ltd Capital/Financing Update 2022

May 15, 2022

59231_rns_2022-05-15_134026f5-4338-4ec6-8b95-5f0fef2811ef.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [178 x 49] intentionally omitted <==

Ref. No.: WOCK/SEC/SE/2022-23/007

15[th] May, 2022

BSE Limited National Stock Exchange of India Limited Corporate Relations Department Exchange Plaza P J Towers, Dalal Street Bandra Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 532300 NSE Symbol: WOCKPHARMA

Sub: Statement on Deviation or Variation of funds raised through Rights Issue for the quarter ended 31[st] March, 2022

Dear Sir/Madam,

Pursuant to Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, we hereby confirm that there has been no deviation in the utilisation of Issue proceeds from the objects as stated in the Letter of Offer for Rights Issue dated 4[th] March 2022.

The ‘Statement of deviation’, confirming Nil deviation, duly reviewed by the Audit Committee is attached herewith as ‘ Annexure A ’.

Kindly take the above information on record.

Thanking you,

for Wockhardt Limited

==> picture [121 x 55] intentionally omitted <==

Debashis Dey Company Secretary

Encls: A/a.

==> picture [112 x 49] intentionally omitted <==

==> picture [513 x 32] intentionally omitted <==

Annexure A

==> picture [178 x 49] intentionally omitted <==

Statement of Deviation / Variation in utilisation of funds raised

Name of the Company Wockhardt Limited
Mode of Fund Raising Rights Issue
Date of Raising Funds 28-03-2021
Amount Raised (in Rs. Crores) 748
Report filed for Quarter ended 31-03-2022
Monitoring Agency Applicable
Monitoring Agency Name, if applicable Care Ratings Limited
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in NA
terms of a contract or objects, which was approved by
the shareholders
If Yes, Date of shareholder Approval NA
Explanation for the Deviation / Variation NA
Comments of the Audit Committee after review No Deviation
Comments of the auditors, if any NA

Objects for which funds have been raised and where there has been a deviation, in the following table

Original Object ModifiedObject, if OriginalAllocation Modifiedallocatio FuUt ndsilised Amount ofDeviation/Variatio Remarks if any
any (Rs. incrore) n, if any n for the quarteraccording toapplicable object
Repayment, in full or part, ofcertain subordinated debtand certain outstandingborrowings (including No 590 Nil 500 Nil NA
interest) availed by theCompany
General corporatepurposes No 152 Nil 55 .40 Nil NA
Total Net Proceeds* 742 55 5.40
  • Excluding estimated ‘Issue related expenses’.

Deviation or variation could mean:

(a) Deviation in the objects or purposes for which the funds have been raised or

(b) Deviation in the amount of funds actually utilized as against what was originally disclosed or

(c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc

==> picture [121 x 56] intentionally omitted <==

Name of the Signatory : Debashis Dey

Designation : Company Secretary & Compliance Officer

==> picture [112 x 49] intentionally omitted <==

==> picture [513 x 32] intentionally omitted <==